相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy
Jahan J. Mohiuddin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Gut microbial metabolites as multi-kingdom intermediates
Kimberly A. Krautkramer et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Microbiome-gut-brain axis in cancer treatment-related psychoneurological toxicities and symptoms: a systematic review
Byron Chang Song et al.
SUPPORTIVE CARE IN CANCER (2021)
Effects of dietary fibre intake in chemotherapy-induced mucositis in murine model
B. Gallotti et al.
BRITISH JOURNAL OF NUTRITION (2021)
Infection trains the host for microbiota-enhanced resistance to pathogens
Apollo Stacy et al.
CELL (2021)
Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals
Francesco Asnicar et al.
NATURE MEDICINE (2021)
Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes
Moamen M. Elmassry et al.
PLOS ONE (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice
Se-Hoon Lee et al.
NATURE MICROBIOLOGY (2021)
Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites
Claudia Grajeda-Iglesias et al.
Aging-US (2021)
Dysbiotic stress increases the sensitivity of the tumor vasculature to radiotherapy and c-Met inhibitors
Samir V. Jenkins et al.
ANGIOGENESIS (2021)
TNF in the era of immune checkpoint inhibitors: friend or foe?
Allen Y. Chen et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers
Molly B. El Alam et al.
PLOS ONE (2021)
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar et al.
SCIENCE (2021)
Common Oral Medications Lead to Prophage Induction in Bacterial Isolates from the Human Gut
Steven G. Sutcliffe et al.
VIRUSES-BASEL (2021)
Bifidobacterium Strain-Specific Enhances the Efficacy of Cancer Therapeutics in Tumor-Bearing Mice
Youngmin Yoon et al.
CANCERS (2021)
Analysis of Gut Microbiome Using Explainable Machine Learning Predicts Risk of Diarrhea Associated With Tyrosine Kinase Inhibitor Neratinib: A Pilot Study
Chi Wah Wong et al.
FRONTIERS IN ONCOLOGY (2021)
Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation
Travis T. Sims et al.
COMMUNICATIONS BIOLOGY (2021)
Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice
C. V. Grant et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
Safae Terrisse et al.
CELL DEATH AND DIFFERENTIATION (2021)
Circadian rhythms and the gut microbiome synchronize the host's metabolic response to diet
Diana E. Gutierrez Lopez et al.
CELL METABOLISM (2021)
The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer differ based on PD-L1 expression
Nobuaki Ochi et al.
EUROPEAN JOURNAL OF CANCER (2021)
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Kai Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers
Oumaima Zidi et al.
MOLECULES (2021)
Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
Caitlin A. Brennan et al.
MBIO (2021)
Probiotic Supplements on Oncology Patients' Treatment-Related Side Effects: A Systematic Review of Randomized Controlled Trials
Miguel Rodriguez-Arrastia et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice
Sharon Ann Barretto et al.
MICROBIOME (2021)
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Alessio Cortellini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer
Julie Veziant et al.
CANCERS (2021)
Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain
Mariarosaria Cuozzo et al.
BIOMEDICINES (2021)
Role of microbiota-derived short-chain fatty acids in cancer development and prevention
Rasoul Mirzaei et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
Lito E. Papanicolas et al.
BMC CANCER (2021)
The gut microbiome: what the oncologist ought to know
K. A. Lee et al.
BRITISH JOURNAL OF CANCER (2021)
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Miles C. Andrews et al.
NATURE MEDICINE (2021)
Influence of immunomodulatory drugs on the gut microbiota
Inessa Cohen et al.
TRANSLATIONAL RESEARCH (2021)
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients
Florent Malard et al.
NATURE COMMUNICATIONS (2021)
Biotransformation of Doxorubicin Promotes Resilience in Simplified Intestinal Microbial Communities
Ryan A. Blaustein et al.
MSPHERE (2021)
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Tomi Jun et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
Lisa Haas et al.
NATURE CANCER (2021)
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
Lucia Lione et al.
ONCOIMMUNOLOGY (2021)
Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors
Louis Gaucher et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers
Allyson L. Byrd et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma
Nazli Dizman et al.
CANCER MEDICINE (2021)
Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer
Zhe Zhao et al.
THORACIC CANCER (2021)
Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia
Jessica R. Galloway-Pena et al.
CLINICAL INFECTIOUS DISEASES (2020)
Potential Effect of Immunotherapy Agents on Cognitive Function in Cancer Patients
Florence Joly et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials
M. Chalabi et al.
ANNALS OF ONCOLOGY (2020)
Relationship Between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib
Kenta Yamamoto et al.
ANTICANCER RESEARCH (2020)
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs
Aaron R. Hansen et al.
CANCER (2020)
When Rhythms Meet the Blues: Circadian Interactions with the Microbiota-Gut-Brain Axis
Emily M. Teichman et al.
CELL METABOLISM (2020)
You've got male: Sex and the microbiota-gut-brain axis across the lifespan
Minal Jaggar et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2020)
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
Andrea Botticelli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Candice R. Gurbatri et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The gut microbiome: an orchestrator of xenobiotic metabolism
Stephanie L. Collins et al.
ACTA PHARMACEUTICA SINICA B (2020)
Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
Eva Rajha et al.
GASTROENTEROLOGY REPORT (2020)
Impact of host and environmental factors on beta-glucuronidase enzymatic activity: implications for gastrointestinal serotonin
Jacinta Walsh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Enhanced Characterization of Drug Metabolism and the Influence of the Intestinal Microbiome: A Pharmacokinetic, Microbiome, and Untargeted Metabolomics Study
Alan K. Jarmusch et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen et al.
EMBO MOLECULAR MEDICINE (2020)
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa et al.
EUROPEAN UROLOGY (2020)
Predictable modulation of cancer treatment outcomes by the gut microbiota
Yoshitaro Heshiki et al.
MICROBIOME (2020)
Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy
Aadra P. Bhatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman et al.
SCIENCE (2020)
Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin
Jacinta Walsh et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal et al.
NATURE COMMUNICATIONS (2020)
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
Clelia Coutzac et al.
NATURE COMMUNICATIONS (2020)
Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion
Wenfan Ke et al.
NATURE COMMUNICATIONS (2020)
Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
Jen-Tsan Chi et al.
CANCER MEDICINE (2020)
Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
Fausto Petrelli et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
Lidia Sanchez-Alcoholado et al.
CANCERS (2020)
Effects of gut microbiota on in vivo metabolism and tissue accumulation of cytochrome P450 3A metabolized drug: Midazolam
Masao Togao et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2020)
Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
Yusuke Tomita et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Pitfalls and novel experimental approaches to optimize microbial interventions for chemotherapy-induced gastrointestinal mucositis
Ana R. da Silva Ferreira et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2020)
Antibiotics Modulate Chemotherapy Efficacy in Patients with Esophageal Cancer
Chensi Wu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
Motoo Nomura et al.
JAMA NETWORK OPEN (2020)
Human postprandial responses to food and potential for precision nutrition
Sarah E. Berry et al.
NATURE MEDICINE (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy
Binbin Lin et al.
JOURNAL OF HEADACHE AND PAIN (2020)
The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment
Courtney B. Subramaniam et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade
Shan Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma
Gianluca Ianiro et al.
NATURE COMMUNICATIONS (2020)
Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
Brendan A. Daisley et al.
NATURE COMMUNICATIONS (2020)
Changes of Intestinal Microbiota in Ovarian Cancer Patients Treated with Surgery and Chemotherapy
Jinfei Tong et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance
Linlin Shi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress
Zsanett Sari et al.
CANCERS (2020)
Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress
Zsanett Sari et al.
CANCERS (2020)
Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening
Thomas Hueso et al.
GUT MICROBES (2020)
Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types
Amit A. Kulkarni et al.
ESMO OPEN (2020)
Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer
Pamela Vernocchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Glioma and temozolomide induced alterations in gut microbiome
Anthony Patrizz et al.
SCIENTIFIC REPORTS (2020)
Evolved bacterial resistance against fluoropyrimidines can lower chemotherapy impact in the Caenornabditis elegans host
Brittany Rosener et al.
ELIFE (2020)
The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A Pilot Study
Wei Shi et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer
Veronica Ghini et al.
CANCERS (2020)
Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma
Angelo Limeta et al.
JCI INSIGHT (2020)
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients
Ilaria Grazia Zizzari et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis
Jessica Emily Green et al.
GUT MICROBES (2020)
Antibiotic administration shortly before or after immunotherapy initiation is correlated with poor prognosis in solid cancer patients: An up-to-date systematic review and meta-analysis
Mengxue Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Gastrointestinal side effects of cancer treatments
Mary O'Reilly et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
A Pilot Study: Changes of Intestinal Microbiota of Patients With Non-small Cell Lung Cancer in Response to Osimertinib Therapy
Jing Cong et al.
FRONTIERS IN MICROBIOLOGY (2020)
Host variables confound gut microbiota studies of human disease
Ivan Vujkovic-Cvijin et al.
NATURE (2020)
Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times
Christian Bailly et al.
NAR CANCER (2020)
The aryl hydrocarbon receptor as a mediator of host-microbiota interplay
Fangcong Dong et al.
GUT MICROBES (2020)
A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult
Ziad Al Nabhani et al.
IMMUNITY (2019)
The microbiome, cancer, and cancer therapy
Beth A. Helmink et al.
NATURE MEDICINE (2019)
Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions
Gerard Clarke et al.
PHARMACOLOGICAL REVIEWS (2019)
Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
Anukriti Sharma et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
Noriho Lida et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Jason Lloyd-Price et al.
NATURE (2019)
The role of short-chain fatty acids in microbiota-gut-brain communication
Boushra Dalile et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy
Concetta Elisa Onesti et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Mapping human microbiome drug metabolism by gut bacteria and their genes
Michael Zimmermann et al.
NATURE (2019)
Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Sreyan Chowdhury et al.
NATURE MEDICINE (2019)
Probiotics Lactobacillus reuteri Abrogates Immune Checkpoint Blockade-Associated Colitis by Inhibiting Group 3 Innate Lymphoid Cells
Tingting Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
The association between fecal enterotoxigenic B. fragilis with colorectal cancer
Fakhri Haghi et al.
BMC CANCER (2019)
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme et al.
CELL (2019)
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Sunny H. Wong et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Prevotella copri is associated with carboplatin-induced gut toxicity
Chaoheng Yu et al.
CELL DEATH & DISEASE (2019)
Consistent and correctable bias in metagenomic sequencing experiments
Michael R. McLaren et al.
ELIFE (2019)
Anti-TNF-α therapy alters the gut microbiota in proteoglycan-induced ankylosing spondylitis in mice
Bin Liu et al.
MICROBIOLOGYOPEN (2019)
Antibiotic therapy augments the efficacy of gemcitabine-containing regimens for advanced cancer: a retrospective study
Hiroo Imai et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis
Cassandra Elise Gheorghe et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
Metabolomic adaptations and correlates of survival to immune checkpoint blockade
Haoxin Li et al.
NATURE COMMUNICATIONS (2019)
Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice
B. R. Loman et al.
SCIENTIFIC REPORTS (2019)
Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review
J. Pierrard et al.
CURRENT ONCOLOGY (2019)
Healthy infants harbor intestinal bacteria that protect against food allergy
Taylor Feehley et al.
NATURE MEDICINE (2019)
Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain
Chandran Ramakrishna et al.
SCIENTIFIC REPORTS (2019)
Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade
Feng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A-ATM-p53 signaling pathway
Maiyon Park et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Drug-gut microbiota interactions: implications for neuropharmacology
Jacinta Walsh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Gut Microbiota-Immune-Brain Interactions in Chemotherapy-Associated Behavioral Comorbidities
Kelley R. Jordan et al.
CANCER (2018)
The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective
Sofia Cussotto et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2018)
The gut microbiota influences anticancer immunosurveillance and general health
Bertrand Routy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies
Karen S. Sfanos et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model
Ching-Wei Chang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis
Hannah R. Wardill et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2018)
Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis
Diana Groza et al.
ONCOIMMUNOLOGY (2018)
Extensive impact of non-antibiotic drugs on human gut bacteria
Lisa Maier et al.
NATURE (2018)
Regional variation limits applications of healthy gut microbiome reference ranges and disease models
Yan He et al.
NATURE MEDICINE (2018)
Microbial tryptophan catabolites in health and disease
Henrik M. Roager et al.
NATURE COMMUNICATIONS (2018)
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients
Oluwaseun Shogbesan et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang et al.
NATURE MEDICINE (2018)
The economic case for precision medicine
Sean P. Gavan et al.
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2018)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Gut microbiota is critical for the induction of chemotherapy-induced pain
Shiqian Shen et al.
NATURE NEUROSCIENCE (2017)
Gut microbiota modulation of chemotherapy efficacy and toxicity
James L. Alexander et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
Chemical transformation of xenobiotics by the human gut microbiota
Nitzan Koppel et al.
SCIENCE (2017)
Fusobacterium's link to colorectal neoplasia sequenced: A systematic review and future insights
Hisham Hussan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Patrice D. Cani et al.
FRONTIERS IN MICROBIOLOGY (2017)
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Arthur E. Frankel et al.
NEOPLASIA (2017)
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast et al.
CANCER RESEARCH (2017)
In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions
Qiang Zhang et al.
DRUG METABOLISM AND DISPOSITION (2017)
Introduction to the human gut microbiota
Elizabeth Thursby et al.
BIOCHEMICAL JOURNAL (2017)
Proton pump inhibitors affect the gut microbiome
Floris Imhann et al.
GUT (2016)
The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia
Jessica R. Galloway-Pena et al.
CANCER (2016)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Ara Koh et al.
CELL (2016)
The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries
Aural Kamal Abdel-Aziz et al.
EXPERIMENTAL NEUROLOGY (2016)
Natural Product Anacardic Acid from Cashew Nut Shells Stimulates Neutrophil Extracellular Trap Production and Bactericidal Activity
Andrew Hollands et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat
John R. Kelly et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
Krista Dubin et al.
NATURE COMMUNICATIONS (2016)
Microbiome mediation of infections in the cancer setting
Ying Taur et al.
GENOME MEDICINE (2016)
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection
Emmanuel Montassier et al.
GENOME MEDICINE (2016)
Roles of UGT, P450, and Gut Microbiota in the Metabolism of Epacadostat in Humans
Jason Boer et al.
DRUG METABOLISM AND DISPOSITION (2016)
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
S. M. O'Mahony et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors
Sumanta K. Pal et al.
CLINICAL CANCER RESEARCH (2015)
Polypharmacy in patients with advanced cancer and the role of medication discontinuation
Thomas W. LeBlanc et al.
LANCET ONCOLOGY (2015)
The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: A systematic review
S. W. M. C. Maass et al.
MATURITAS (2015)
Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice
Silvia H. S. P. Pedroso et al.
MICROBIOLOGY-SGM (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice
Felcy Pavithra Selwyn et al.
TOXICOLOGICAL SCIENCES (2015)
Gut microbiome and anticancer immune response: really hot Sh☆t!
S. Viaud et al.
CELL DEATH AND DIFFERENTIATION (2015)
Bile acids and the gut microbiome
Jason M. Ridlon et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
A Meta-Analysis of Cognitive Impairment Following Adult Cancer Chemotherapy
Oana C. Lindner et al.
NEUROPSYCHOLOGY (2014)
16S rRNA Gene Pyrosequencing Reveals Shift in Patient Faecal Microbiota During High-Dose Chemotherapy as Conditioning Regimen for Bone Marrow Transplantation
Emmanuel Montassier et al.
MICROBIAL ECOLOGY (2014)
Bacteria as vitamin suppliers to their host: a gut microbiota perspective
Jean Guy LeBlanc et al.
CURRENT OPINION IN BIOTECHNOLOGY (2013)
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa et al.
NATURE (2013)
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Nicholas Arpaia et al.
NATURE (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud et al.
SCIENCE (2013)
Selected Toxicities of Targeted Therapies: Presentation and Management
Christian Kollmannsberger et al.
SEMINARS IN ONCOLOGY (2013)
Oral Supplementation of Butyrate Reduces Mucositis and Intestinal Permeability Associated with 5-Fluorouracil Administration
Talita Mayra Ferreira et al.
LIPIDS (2012)
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
John F. Cryan et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Influence of Tryptophan Contained in 1-Methyl-Tryptophan on Antimicrobial and Immunoregulatory Functions of Indoleamine 2,3-Dioxygenase
Silvia K. Schmidt et al.
PLOS ONE (2012)
The Inhibitory Receptor PD-1 Regulates IgA Selection and Bacterial Composition in the Gut
Shimpei Kawamoto et al.
SCIENCE (2012)
Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors Focus on Pyrimidines, Pyridines and Pyrroles
Paola Di Gion et al.
CLINICAL PHARMACOKINETICS (2011)
Changes in Human Fecal Microbiota Due to Chemotherapy Analyzed by TaqMan-PCR, 454 Sequencing and PCR-DGGE Fingerprinting
Jutta Zwielehner et al.
PLOS ONE (2011)
Gut Microbiota in Health and Disease
Inna Sekirov et al.
PHYSIOLOGICAL REVIEWS (2010)
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Bret D. Wallace et al.
SCIENCE (2010)
Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
Alexander Stein et al.
Therapeutic Advances in Medical Oncology (2009)
Diminished quality of life in patients with cancer correlates with tryptophan degradation
Katharina Schroecksnadel et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Metagenomic analysis of the human distal gut microbiome
Steven R. Gill et al.
SCIENCE (2006)
Pharmacogenomics in cancer therapy: is host genome variability important?
WP Petros et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
分享论文
